# A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

> **NCT00463385** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 88 (actual)

## Conditions studied

- Myelofibrosis With Myeloid Metaplasia
- Myeloid Metaplasia
- Myelofibrosis

## Interventions

- **DRUG:** Pomalidomide
- **DRUG:** Prednisone
- **DRUG:** Placebo to pomalidomide
- **DRUG:** Placebo to prednisone

## Key facts

- **NCT ID:** NCT00463385
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04-01
- **Primary completion:** 2009-05-01
- **Final completion:** 2013-12-31
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463385, "A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00463385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*